Finally, we show that the marked neuroprotective effects of cooling in prion-diseased mice are abolished by pharmacological inhibition of the pathway by preventing RBM3 induction, highlighting its relevance as a novel target for therapeutic modulation for neurodegenerative diseases. This evidence concerns the gene RBM3 and neurodegenerative disease.